$2,950,000 of ALTRIA CLIENT SERVICES LLC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products Department of Homeland Security Appropriations Act 2027; potential provisions related to tobacco and nicotine products Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products Commerce Justice Science and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products HR 7148: FY2026 Consolidated Defense, Labor-HHS, Nat. Sec.-State, Transportation Housing and Urban Development, Financial Services and General Government Appropriations Act; provisions related to tobacco and nicotine products HR 6938: FY2026 Consolidated Commerce Justice Science, Energy & Water, Interior Appropriations Act; provisions related to contraband vapor products and the Organized Crime Drug Enforcement Task Force HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill"
You can find more data on corporate lobbying on Quiver Quantitative.
MO Insider Trading Activity
MO insiders have traded $MO stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MO stock by insiders over the last 6 months:
- CHARLES N. WHITAKER (SVP, Chief HR Off. & CCO) sold 27,908 shares for an estimated $1,885,718
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MO Hedge Fund Activity
We have seen 1,112 institutional investors add shares of MO stock to their portfolio, and 1,010 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 18,349,454 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $1,058,029,517
- PACER ADVISORS, INC. removed 7,078,893 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $408,168,970
- CAPITAL WORLD INVESTORS removed 6,590,723 shares (-26.3%) from their portfolio in Q4 2025, for an estimated $380,021,088
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 6,265,780 shares (+10.6%) to their portfolio in Q4 2025, for an estimated $361,284,874
- BLACKROCK, INC. added 4,062,887 shares (+3.2%) to their portfolio in Q4 2025, for an estimated $234,266,064
- JPMORGAN CHASE & CO removed 2,653,857 shares (-22.0%) from their portfolio in Q4 2025, for an estimated $153,021,394
- AMERIPRISE FINANCIAL INC added 2,230,517 shares (+11.4%) to their portfolio in Q4 2025, for an estimated $128,611,610
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MO Analyst Ratings
Wall Street analysts have issued reports on $MO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 01/30/2026
To track analyst ratings and price targets for MO, check out Quiver Quantitative's $MO forecast page.
MO Price Targets
Multiple analysts have issued price targets for $MO recently. We have seen 5 analysts offer price targets for $MO in the last 6 months, with a median target of $68.0.
Here are some recent targets:
- Lisa Lewandowski from B of A Securities set a target price of $73.0 on 04/10/2026
- Faham Baig from UBS set a target price of $74.0 on 03/09/2026
- Gaurav Jain from Barclays set a target price of $63.0 on 02/23/2026
- Simon Hales from Citigroup set a target price of $65.0 on 02/09/2026
- Matthew Smith from Stifel set a target price of $68.0 on 01/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
